ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Prognostic scoring systems for newly diagnosed chronic myeloid leukemia*

Prognostic scoring systems for newly diagnosed chronic myeloid leukemia*
Scoring system Calculator Link Risk groups
EUTOS score[1] www.leukemia-net.org/content/leukemias/cml/eutos_score/ Low risk, high risk
Euro (Hasford) score[2] www.leukemia-net.org/content/leukemias/cml/euro__and_sokal_score/ Low risk, intermediate risk, high risk
Sokal score[3] www.leukemia-net.org/content/leukemias/cml/euro__and_sokal_score/ Low risk, intermediate risk, high risk
The EUTOS long-term survival score (ELTS)[4] www.leukemia-net.org/content/leukemias/cml/elts_score/ Low risk, intermediate risk, high risk
* These scoring systems were designed for patients with newly diagnosed chronic myeloid leukemia (CML) who have not yet received any treatment, including hydroxyurea. In addition, the EUTOS score was specifically designed to predict outcomes among patients undergoing initial treatment with imatinib.
References:
  1. Hasford J, Baccarani M, Hoffmann V, et al. Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score. Blood 2011; 118:686.
  2. Hasford J, Pfirrmann M, Hehlmann R, et al. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group. J Natl Cancer Inst 1998; 90:850.
  3. Sokal JE, Cox EB, Baccarani M, et al. Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood 1984; 63:789.
  4. Pfirrmann M, Baccarani M, Saussele S, et al. Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia. Leukemia 2016; 30:48.
Graphic 60446 Version 8.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟